RX News - Candlesense

BioSyent Declares Third Quarter 2025 Dividend

MISSISSAUGA, Ontario, Aug. 21, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly divi...

Dividends

20 days ago

BioSyent Schedules Q2 and H1 2025 Earnings Release for August 21, 2025

MISSISSAUGA, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months and six months ende...

What was the market reaction to the earnings release and how is the stock's price action aligning with the reported results? Are there any significant changes in the company's gross margin or R&D spend that could influence profitability trends? Did the management commentary highlight any macro‑economic or regulatory risks that could impact the company's short‑term performance?

Earnings

27 days ago